Can viewing a virtual reality video as part of preoperative information reduce anxiety before a caesarean section?

ISRCTN ISRCTN74794447
DOI https://doi.org/10.1186/ISRCTN74794447
Secondary identifying numbers N17.017
Submission date
05/11/2019
Registration date
05/11/2019
Last edited
19/12/2019
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Pregnancy and Childbirth
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Background and study aims
The aim of this study is to investigate whether adding a virtual reality video to standard preoperative information before a caesarean delivery reduces anxiety in patients and their partners.

Who can participate?
Women older than 18 with a term pregnancy, scheduled for a caesarean delivery

What does the study involve?
Participants are randomly allocated to either the virtual reality group or the control group. The latter only receives standard preoperative information. Patients in the VR group receive a short virtual reality video which shows all aspects of the caesarean delivery.

What are the possible benefits and risks of participating?
Women who are allocated to the VR group receive additional pre-operative information. There is a risk of motion sickness after watching the VR video, but this risk is minimal.

Where is the study run from?
Máxima Medical Centre Veldhoven (Netherlands)

When is the study starting and how long is it expected to run for?
November 2016 to January 2018

Who is funding the study?
Máxima Medical Centre Veldhoven (Netherlands)

Who is the main contact?
Lore Noben
Lore.noben@mmc.nl

Contact information

Ms Lore Noben
Scientific

PO Box 7777
Veldhoven
5500 MB
Netherlands

ORCiD logoORCID ID 0000-0002-4894-0873
Phone +31 (0)40 888 8384
Email Lore.noben@mmc.nl

Study information

Study designSingle-centre randomized controlled trial.
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typePrevention
Scientific titleA virtual reality video to improve INFOrmation provision and to reduce anxiety before a Caesarean delivery: INFO-C trial
Study acronymINFO-C
Study objectivesAdding the virtual reality (VR) video to standard preoperative information causes a significant decrease in preoperative anxiety. Furthermore, we expected a positive effect of VR on levels of anxiety and patient satisfaction scores of both women and their partners. Third, this study was conducted to check whether VR would be feasible to implement without causing any harming side effects such as motion sickness.
Ethics approval(s)On 15/06/2015 the researchers received a statement from their local institutional review board that no ethics approval was required (METC Máxima MC, PO Box 7777, 5500 MB Veldhoven, De Run 4600, 5504 DB Veldhoven; Tel: +31 (0)40 888 95 28; Email: metc@mmc.nl), N17.017
Health condition(s) or problem(s) studiedPreoperative anxiety
InterventionThe intervention comprised a 360° virtual reality video, in addition to standard preoperative information. The control group only received standard preoperative information. Randomization was performed using an online computer randomizer by means of stratified block randomization. Stratification was done based on history of emergency caesarean delivery (yes or no).
Intervention typeOther
Primary outcome measureAnxiety measured using the Visual Analogue scale for anxiety (VAS-A) at the time of inclusion and at admittance on the ward
Secondary outcome measures1. Patient satisfaction measured by means of questionnaires and filled in 1 to 2 weeks after the caesarean delivery
2. Motion sickness assessed using simulation sickness questionnaire filled in by participants from the VR group immediately after watching the VR video
Overall study start date01/11/2016
Completion date31/01/2018

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexFemale
Target number of participants80
Total final enrolment97
Key inclusion criteria1. Women over the age of 18
2. Planned for a primary caesarean delivery
3. No history of caesarean delivery or history of an emergency caesarean delivery
4. Gestational age above 37 weeks
Key exclusion criteria1. A history of a primary caesarean delivery
2. Insufficient understanding of the Dutch language
3. Prematurity (gestational age below 37 weeks)
4. Placenta praevia
5. Pre-eclampsia
6. Suspected congenital anomaly
Date of first enrolment11/11/2016
Date of final enrolment28/12/2017

Locations

Countries of recruitment

  • Netherlands

Study participating centre

Máxima Medical Centre
P.O. box 7777
Veldhoven
5500MB
Netherlands

Sponsor information

Máxima Medical Centre
Hospital/treatment centre

PO Box 7777
Veldhoven
5500 MB
Netherlands

Phone +31 (0)40 888 8384
Email Lore.noben@mmc.nl
Website https://www.mmc.nl/
ROR logo "ROR" https://ror.org/02x6rcb77

Funders

Funder type

Hospital/treatment centre

Máxima Medical Centre

No information available

Results and Publications

Intention to publish date01/12/2019
Individual participant data (IPD) Intention to shareYes
IPD sharing plan summaryAvailable on request
Publication and dissemination planPublication of the results in the Journal of Medical Internet Research (JMIR) Mental Health, accepted for publication.

L. Noben, S.M.T.A. Goossens, S.E.M. Truijens, M.M.G. van Berckel, C.W. Perquin, G.D. Slooter, S.J. van Rooijen. A virtual reality video to improve information provision and to reduce anxiety before a cesarean delivery: a randomized controlled trial. JMIR. (Accepted for Publication)
IPD sharing planThe datasets generated during and/or analysed during the current study are/will be available upon request from Lore Noben (lore.noben@mmc.nl).

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 18/12/2019 19/12/2019 Yes No

Editorial Notes

19/12/2019: The following changes have been made:
1. Publication reference added.
2. The total final enrolment number has been added from the reference.
05/11/2019: Trial's existence confirmed by ethics committee.